Elda

Researchers are collecting detailed information about patients with venous thromboembolism (VTE), which includes blood clots in veins such as deep-vein thrombosis and pulmonary embolism. The project aims to improve doctors' understanding of VTE, especially in patients often excluded from clinical trials, like pregnant women, elderly individuals, cancer patients, and those with other complex health issues. The goal is to reduce deaths, clot recurrence, bleeding problems, and artery-related events by sharing this knowledge widely. The study involves gathering extensive data on each patient's health status, treatments, and outcomes during the first three months of therapy. This registry is available online to help doctors quickly find information on patients with similar medical profiles and make informed decisions about managing high-risk individuals. There are no specific interventions being tested; instead, the focus is on collecting real-world patient data. Participants provide informed consent and are followed for at least three years to monitor for new clot events and complications. Researchers track recurrences of VTE, bleeding episodes, and deaths, aiming to create tools that predict which patients are most at risk for problems. This ongoing data collection supports improving care and guiding treatment decisions for diverse patient groups over time.

This research aims to create a web-based database for epidemiological and clinical research on esophageal and stomach cancer. The database will be accessible to members of the AGAMENON - SEOM group and is designed to ensure careful collection, analysis, and use of patient data. This effort intends to improve understanding of these cancers to optimize patient management, treatment, and outcomes, as well as facilitate comparison with other studies and enhance the quality of scientific publications. Patient data will be collected retrospectively from medical records. The treatments recorded include surgery, chemotherapy, anti-targeted agents, immunotherapy, and radiotherapy. These interventions represent common approaches used in managing esophagogastric cancers and will be documented in the database to support research and analysis. Participants in the study must be adults diagnosed with carcinoma of the esophagus, gastroesophageal junction, or stomach, with at least three months of follow-up clinical information unless early death occurred. Researchers will analyze diagnostic and therapeutic approaches over up to 12 months. Data completeness is essential, and patients whose information cannot be fully obtained will be excluded. The study covers a wide age range from 18 to 100 years and includes all genders.

This observational, multicenter study focuses on patients diagnosed with lung cancer and other thoracic tumors. It aims to improve treatment and prognosis by exploring patient data related to the expression of markers that predict responses to chemotherapy and molecular inhibitors. The study reflects a commitment to individualized treatment and understanding the epidemiology of thoracic tumors in Spain, addressing the high mortality and variability in diagnosis and treatment. The study collects information both retrospectively and prospectively from clinical histories of patients treated by thoracic surgeons and medical oncologists. It investigates epidemiological and therapeutic factors associated with thoracic tumors, including lung cancer, to support strategies like multidisciplinary care and early diagnosis. There are no interventions or treatments assigned, as this is an observational registry gathering comprehensive real-world data. Participants will have their clinical data reviewed to describe characteristics of lung cancer and other thoracic tumors over up to 10 years. The study aims to explore the epidemiology and treatment approaches, supporting future improvements in care. There is no age or gender restriction, and data collection includes both patients receiving active treatment and those under palliative care. The study duration, follow-up, and specific assessments are based on patient records and available medical information.